Masupirdine is an investigational new drug that is being evaluated for the treatment of agitation in Alzheimer's dementia. It is a selective 5-HT6 receptor antagonist.
See also List of investigational agitation drugs List of investigational antipsychotics List of investigational cognition and memory disorder drugs List of investigational Parkinson's disease drugs
References